This inventor holds 1 USPTO granted patent. Top assignee: Schering Aktiengesellschaft. Active years: 1986.
Company Filing History:
Years Active: 1986
Title: **Gertrud Schroder: Innovator in Antihypertensive Research**
Introduction
Gertrud Schroder is a distinguished inventor based in Berlin, Germany, known for her significant contributions to medical research, particularly in the field of antihypertensive treatments. With one notable patent under her name, Dr. Schroder has played a vital role in advancing the understanding and treatment of essential hypertonia.
Latest Patents
Gertrud Schroder holds a patent for "Terguride as Antihypertensive." This innovative discovery involves Terguride and its physiologically compatible salts, which have proven useful in the treatment of essential hypertonia in humans. The recommended dosage range of 0.1-1.0 mg/day highlights the precision and care that went into developing this therapeutic agent.
Career Highlights
Throughout her career, Gertrud has worked at Schering Aktiengesellschaft, where she has contributed significantly to pharmaceutical research. Her work focuses on developing effective medications that address critical health issues, showcasing her commitment to improving patient outcomes.
Collaborations
Gertrud Schroder has collaborated with notable professionals, including Wolfgang Kehr and Gunter Stock. Their combined expertise has likely fostered an environment of innovation and shared knowledge, further propelling advancements in their field.
Conclusion
In summary, Gertrud Schroder's contributions to antihypertensive research exemplify her dedication as an inventor and her impact on medical science. Her patented work continues to play an essential role in treating essential hypertonia, making her a vital figure in the medical innovation landscape.